http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5770862-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_33dafb5bbc2ec47ebcb7becbbe60f704 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4015 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-27 |
filingDate | 1980-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c5a4fbf5063104d360fb2c78c0217f3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb0efafb2c58ae022bcddd9c28ba94ec http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d68cc478630e9cd2fdf8f8116891fb8 |
publicationDate | 1982-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-S5770862-A |
titleOfInvention | 2-pyrrolidone derivative |
abstract | NEW MATERIAL:A 2-pyrrolidone derivative shown by the formulaI(m is 2 or 3. n is 0 or 1). n EXAMPLE: A compound shown by the formula II. n USE: A drug, e.g., antitumor agent. n PROCESS: A compound, e.g., farnesylacetic acid methyl ester, etc. shown by the formula III (X is group, e.g., OH, alkoxy, halogen, -O-alkali metal, etc., capable of reacting with an alcoholic hydroxy group or an organic halide to form an ester) is reacted with a compound, e.g., N-β-hydroxyethyl-2-pyrrolidone, etc. shown by the formula IV (Y is OH or halogen), if necessary, in the presence of a catalyst for ester formation, to give a compound shown by the formulaI. n COPYRIGHT: (C)1982,JPO&Japio |
priorityDate | 1980-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 23.